Keyphrases
Liver
100%
Immunosuppression
100%
Mycophenolate Mofetil
100%
Transplanted Patients
100%
Calcineurin Inhibitors
54%
Liver Transplantation
27%
Monotherapy
27%
Adverse Events
27%
Urea
18%
Creatinine
18%
Chronic Renal Insufficiency
18%
Hypertension
9%
Liver Function
9%
Acute Rejection
9%
Prolonged Use
9%
Dyslipemia
9%
Close Monitoring
9%
Creatinine Clearance
9%
Early Conversion
9%
Conversion Period
9%
Medicine and Dentistry
Mycophenolate Mofetil
100%
Immunosuppressive Treatment
100%
Calcineurin Inhibitor
54%
Adverse Event
27%
Monotherapy
27%
Liver Transplantation
27%
Low Drug Dose
18%
Chronic Kidney Disease
18%
Creatinine
18%
Dyslipidemia
9%
Liver Function
9%
Acute Graft Rejection
9%
Creatinine Clearance
9%
Patient with Transplantation
9%
Laromustine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Mycophenolate Mofetil
100%
Calcineurin Inhibitor
54%
Adverse Event
27%
Monotherapy
27%
Creatinine
27%
Chronic Kidney Failure
18%
Dyslipidemia
9%
Acute Graft Rejection
9%
Laromustine
9%
Immunology and Microbiology
Immunosuppression
100%
Mycophenolate Mofetil
100%
Liver Transplantation
27%
Low Drug Dose
18%
Acute Graft Rejection
9%
Liver Function
9%
Creatinine Clearance
9%
Biochemistry, Genetics and Molecular Biology
Calcineurin
100%
Low Drug Dose
33%
Creatinine
33%
Dyslipidemia
16%
Liver Function
16%
Creatinine Clearance
16%